| Hans-Günter Meyer-Thompson | Buprenorphin
Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder.
Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder.
Laffont CM, Ngaimisi E, Gopalakrishnan M, Ivaturi V, Young M, Greenwald MK, Heidbreder C.
Front Pharmacol. 2022 Nov 18;13:1052113. doi: 10.3389/fphar.2022.1052113. PMID: 36467036; PMCID: PMC9715596.